The US Food and Drug Administration (FDA) has approved Lemtrada(TM) (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS), Sanofi and its subsidiary Genzyme have announced.
Cambridge Enterprise, University of Cambridge
Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.
Telephone: +44 (0)1223 760 339
Hauser Forum 3 Charles Babbage Road Cambridge
Post Code: CB3 0GT
Country: United Kingdom
Membership Type: Cambridge University Department